VU
VU is a company that focuses specifically on preventing fraud and safeguarding people's identities through cybersecurity measures. They have developed unique methods of identity authentication incorporating biometrics, geolocation, machine learning, ID card recognition, and analysis of user behavior.
VU is a company that focuses specifically on preventing fraud and safeguarding people's identities through cybersecurity measures. They have developed unique methods of identity authentication incorporating biometrics, geolocation, machine learning, ID card recognition, and analysis of user behavior.
VU has raised $4.2M across 1 round. Its most recent round was a Series Unknown of $4.2M in Apr 2023. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
VU is featured in
Similar companies
BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
Kresko RNAtech is a biotechnology company that offers services for the development and manufacturing of nutraceuticals.
Bioeutectics is committed to improving the sustainability of industrial products and processes by providing superior solvents that are derived from renewable resources, last for a long time, and are environmentally friendly. The company utilizes eutectic technology to replicate the solvent creation process found in plants, using only 100% sustainable resources. This allows them to replace the petrochemical solvents previously used in industrial applications. As a result, they have gained dominance in the market by offering natural alternatives that are beneficial for the environment.
Mycorium Biotech is a biotechnology startup committed to creating sustainable and eco-friendly materials for the fashion industry, among others. Our primary focus is on mycelium-based leather, a revolutionary alternative to traditional leather. It is a sustainable, cruelty-free, scalable, and innovative material that has the potential to revolutionize the fashion industry, among others. Fashion is in the midst of a sustainability crisis; it is not functional. This industry makes +100Bn items, with +20Bn of CO2 emission per year. We are taking steps to reduce its carbon footprint, by growing the next generation of materials. We are pushing the boundaries of sustainable fashion. We work with a team of experts in biotechnology to ensure that our products are not only sustainable but also of the highest quality. Join us on our journey to create a better and more sustainable future for fashion.
We are a biotech startup democratizing genomic sequencing applications with proprietary technology. We developed a reliable and robust solution to bring down the cost of applications in long-read sequencers. Our solution consists in a proprietary technology that enables the invention of a myriad of new long-read applications.
Founded in 2016, Bioheuris develops sustainable weed management systems. The company integrates synthetic biology and gene editing to develop next-generation herbicide resistant crops. Bioheuris expects to bring farmers cost-effective tools that delay weed resistance evolution and reduce environmental impact. With its state-of-the-art technology platforms, HEURIK™ and SWAP™ and strategic alliances with seed and chemical companies, Bioheuris is “Empowering crops® for weed control”.
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Tenon Medical, a biotech firm specializing in enhancing surgical solutions for the SI joint, was established in 2012 in Morgan Hill, California.
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through strategic acquisitions.
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for cancer and blood disorders. They use a special technology called ADAPTIR™ to improve outcomes for cancer patients. The company is known for its supportive work environment, culture of innovation, and unique platform technology. As a result, Aptevo has been able to attract talented individuals with experience in other leading biotech companies such as Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.